Decreasing of p27(Kip1)and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer

scientific article published on May 2001

Decreasing of p27(Kip1)and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1041552234
P356DOI10.1054/BJOC.2000.1736
P932PMC publication ID2363875
P698PubMed publication ID11336477
P5875ResearchGate publication ID12001302

P2093author name stringIto Y
Oshima H
Takagi K
Asami H
Kamai T
Yoshida KI
P2860cites workp27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21Q28505037
Cyclins and cancer. II: Cyclin D and CDK inhibitors come of ageQ29618409
Frequent loss of expression of the cyclin-dependent kinase inhibitor p27 in epithelial ovarian cancerQ33870958
Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27Q33887383
Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancerQ34415244
Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas.Q34415250
Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancerQ34436736
Loss of cyclin-dependent kinase inhibitor p27Kip1 is a novel prognostic factor in localized human prostate adenocarcinomaQ34455472
Deletions of the INK4A gene in superficial bladder tumors. Association with recurrenceQ35787188
Loss of cell cycle regulators p27(Kip1) and cyclin E in transitional cell carcinoma of the bladder correlates with tumor grade and patient survivalQ35788260
High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancerQ35829425
Low p27 expression predicts poor disease-free survival in patients with prostate cancerQ38472792
Altered Expression of Retinoblastoma Protein and Known Prognostic Variables in Locally Advanced Bladder CancerQ38487334
Apparent failure of current intravesical chemotherapy prophylaxis to influence the long-term course of superficial transitional cell carcinoma of the bladderQ40506004
Bacillus Calmette-Guérin in superficial bladder cancer: consensus and controversies.Q40521956
Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancerQ41128730
Overexpression of cyclin D1 correlates with early recurrence in superficial bladder cancersQ41855173
Predictive value of decreased p27Kip1 protein expression for the recurrence-free and long-term survival of prostate cancer patientsQ43201975
Adenoviral expression of the cyclin-dependent kinase inhibitor p27Kip1: a strategy for breast cancer gene therapyQ44951091
Promoting apoptosis: a novel activity associated with the cyclin-dependent kinase inhibitor p27Q64382234
Significance of bladder neck involvement on progression in superficial bladder cancer.Q64986989
Long-term follow-up in patients treated with methotrexate, vinblastine, doxorubicin, and cisplatin (M-VAC) for transitional cell carcinoma of urinary bladder: cause for concernQ69401186
Prognostic factors for survival of patients with advanced urothelial tumors treated with methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapyQ70113435
Superficial bladder cancer: progression and recurrenceQ71108025
Factors influencing the recurrence rate of bladder cancerQ71129954
Deregulation of cyclin E in breast cancerQ72060553
Cancer prognostics: past, present and p27Q73034258
Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patientsQ73034313
Significance of cyclin D1 overexpression in transitional cell carcinomas of the urinary bladder and its correlation with histopathologic featuresQ73048637
p27 expression and gastric carcinomaQ73399997
Prognostic significance of p27Kip1 and Ki-67 expression in carcinoma of the renal pelvis and ureterQ73968082
Loss of P27Kip1 expression correlates with tumor grade and with reduced disease-free survival in primary superficial bladder cancersQ77973231
Reduced expression of the CDK inhibitor p27(KIP1) in rat two-stage bladder carcinogenesis and its association with expression profiles of p21(WAF1/Cip1) and p53Q78198368
Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urotheliumQ93606365
P433issue9
P407language of work or nameEnglishQ1860
P304page(s)1242-1251
P577publication date2001-05-01
P1433published inBritish Journal of CancerQ326309
P1476titleDecreasing of p27(Kip1)and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer
P478volume84